————— Bio-Rad Laboratories

Safety from Blood Bank to Diagnostic

I N F E C T I O U S
D I S E A S E

A new level of effectiveness

T E S T I N G

and safety
 Specificity
Less than 0.17% false positive results
I N F E C T I O U S

Studies on 4,274 fresh blood bank samples

from 3 French blood bank centers. (Results Number Initial Repeat

from Montpellier and Bordeaux correspond

to the official AFSSAPS data).

Sensitivity * False positive sample: sample discrepant with the routine assay not confirmed positive
D I S E A S E

with a third anti-HBc assay and anti-HBs negative.

S.F.T.S. Panel

All samples from the official anti-HBc

1996 panel from the “Société
Française de Transfusion Sanguine”
that should have tested positive
T E S T I N G

did in fact test positive.

Serological
concentration

symptoms
ALT
Profile:
Acute
Hepatitis HBsAg
Anti-HBc

Anti-HBs

Anti-HBc Anti-HBe
IgM
HBeAg
8 12 16 20 24 28 32 36 40 44 52
weeks post infection
 Security
Microplate and strip identification
Both the microplate frame and strips are labeled (product name and batch number)
during the manufacturing process, minimizing manipulation errors.

Deposition proof for samples and reagents

The use of colored reagents allows visual or automated control of sample and
reagents addition. The OD norms specified in the package insert guarantee control
of sample and reagents addition.

Easy-to-Use
• 20 µL for sample. Easy integration
on instrument
• Same TMB substrate, stopping solution and
wash solution for the Bio-Rad microplate virology
screening assays (Hepatitis C, B, and HIV)
• Conjugate ready-to-use
• Stable TMB substrate solution – 6 hours at
room temperature after reconstitution
• No microplate prewash before use
• No toxicity for the substrate (TMB)
• Easy integration on the majority
of microplate instruments

Colored reagents allow visual or automated

control of sample and reagents addition

B I O - R A D L A B O R A T O R I E S
—
—– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – > INFECTIOUS DISEASE TESTING < – – – – – ——
®
Monolisa Anti-HBc Plus

Test Format Deposition Proof

1 Color of well BEFORE dispensing Color of well AFTER dispensing

• Microplate coated with

recombinant HBc antigen
• 200 µL of diluent

• 20 µL of control or sample
• Incubation 30 minutes
at 37°C or 40°C

WASH

2 • 200 µL of conjugate
• Incubation 60 minutes
at 37°C or 40°C

WASH

3 • 100 µL of TMB substrate

• Incubation 30 minutes at room
temperature (18-30°C) in the dark

• 100 µL of stopping solution

• Cut off = R4 O.D. mean/5

READ at dual wave length 450/620-700 nm

HBc Ag * Reactive sample after 30 minutes incubation.

Anti-IgG/IgM
Recombinant Anti-HBc Ab
Conjugate
Proteins

Ordering Information
Catalog No. Description

72315 Monolisa® Anti-HBc Plus ....................................................................................................... 1 microplate

72316 Monolisa® Anti-HBc Plus ...................................................................................................... 5 microplates

Bio-Rad For further information, please contact the Bio-Rad office

Laboratories nearest you or visit our website at www.bio-rad.com.
Ref. 17558 – 60 – 06/2003

Clinical Website www.bio-rad.com U.S. 1-800-2-BIO-RAD Australia 61-2-9914-2800 Austria 43-1-877-8901 Belgium 32-9-385-5511 Brazil 5521-2507-6191 Canada 1-514-334-4372
Czech Republic 420-2-41430532 China 86-21-63052255 Denmark 45-4452-1000 Finland 358-9-804-22-00 France 33-1-4795-6000 Germany 49-89-31884-0 Hong Kong
Diagnostics Group 852-2789-3300 India 91-124-6398112 Israel 972-3-9514127 Italy 39-02-216091 Japan 81-3-5811-6290 Korea 82-2-3473-4460 Latin America 305-894-5950 Mexico 5255-5534-2552
The Netherlands 31-318-540666 New Zealand 64-9-415-2280 Norway 47-23-38-41-30 Poland 48-22-331-99-99 Portugal 351-21-472-7700 Russia 7-095-721-14-00
Singapore 65-6272-9877 South Africa 27-11-442-85-08 Spain 34-91-590-5200 Sweden 46-8-555-127-00 Switzerland 41-61-717-95-55 Thailand 662-651-8311
United Kingdom 44-208-328-2000
DG02-550